Expression of cyclin E and cyclin D1 in non-small cell lung cancers
- 1 January 2001
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 31 (1) , 3-8
- https://doi.org/10.1016/s0169-5002(00)00160-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancerBritish Journal of Cancer, 1999
- Alterations of expression of Rb, p16INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significanceThe Journal of Pathology, 1999
- CYCLIN D1 OVEREXPRESSION IN NON-SMALL CELL LUNG CARCINOMA: CORRELATION WITH Ki67 LABELLING INDEX AND POOR CYTOPLASMIC DIFFERENTIATIONThe Journal of Pathology, 1996
- The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancerLung Cancer, 1996
- Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerBritish Journal of Cancer, 1996
- Cyclin D1 protein expression in lung cancerYonsei Medical Journal, 1996
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.Proceedings of the National Academy of Sciences, 1994
- Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.Genes & Development, 1994
- Mammalian G1 cyclinsCell, 1993